Lonza's Synaffix and Sidewinder Forge Alliance for Next-Gen Bispecific ADC Therapeutics Lonza and Sidewinder Therapeutics have partnered to develop innovative bispecific antibody-drug conjugates (ADCs) aimed at treating solid tumors, leveraging advanced ADC technology.

Lonza's Synaffix and Sidewinder Forge Alliance for Next-Gen Bispecific ADC Therapeutics #None #Synaffix #Lonza #Sidewinder

This work is part of a collaborative effort with #Synaffix, and I look forward to sharing our findings. If you’re attending #OTS, I invite you to visit our poster to learn more about our Validation Lab’s in vitro and in vivo platforms, as well as our new humanized DMD mouse models.

Lonza's Synaffix and Qurient Therapeutics Unite for Innovative ADC Development Lonza's Synaffix collaborates with Qurient Therapeutics to advance dual-payload ADCs aimed at targeting tough cancers, marking a significant step in medical innovation.

Lonza's Synaffix and Qurient Therapeutics Unite for Innovative ADC Development #None #Synaffix #Lonza #Qurient #Amsterdam,_Seongnam-si

Boehringer Ingelheim Expands Cancer Treatment Portfolio through Synaffix Licensing Deal Boehringer Ingelheim boosts its oncology portfolio by licensing innovative ADC technology from Synaffix, aiming to enhance cancer treatment outcomes.

Boehringer Ingelheim Expands Cancer Treatment Portfolio through Synaffix Licensing Deal #Germany #Boehringer_Ingelheim #ADC_technology #Synaffix #Ingelheim

Elevation Oncology Collaborates with Synaffix to Enhance ADC Drug Development Elevation Oncology has secured a licensing agreement with Synaffix for innovative ADC technology to boost their drug development pipeline targeting solid tumors.

Elevation Oncology Collaborates with Synaffix to Enhance ADC Drug Development #Netherlands #Amsterdam #ADC_technology #Synaffix #Elevation_Oncology

Synaffix and Illumina Forge Partnership for Metal-Free Click Chemistry in DNA Sequencing Synaffix has entered into a licensing agreement with Illumina to enhance DNA sequencing technology using its patented metal-free click chemistry, aiming for improved therapeutic applications.

Synaffix and Illumina Forge Partnership for Metal-Free Click Chemistry in DNA Sequencing #Netherlands #Amsterdam #Synaffix #Illumina #Bioconjugation